GUWAHATI, June 1 - Dr Francesco Zanon, MD, FESC (Director of the Laboratory of Electro Physiology & Cardiac Pacing, Rovigo General Hospital, Italy) discussed with the media the benefits of new-age therapies for heart failure through �Cardiac Resynchronization and Multi Point Pacing� recently.
Dr Zanon was in Guwahati to meet the medical fraternity and discuss the attributes of the therapy with doctors in a knowledge-share mission.
Dr Rituparna Baruah of Apollo Hospital, Guwahati, used the device on his patient for the first time in the North East.
�Cardiac Resynchronization Therapy (CRT) with multi-point pacing technology can be used to treat patients with heart failure, a progressive condition in which the heart weakens and loses its ability to pump an adequate supply of blood. This severely restricts patient's quality of life and increases risk of mortality,� he said.
�We expect that by availing this therapy, a patient with heart failure can go back to his normal life. Different studies have shown that MPP is safe, effective and result in superior response to conventional Bi-Ventricular pacing,� he added.
Dr Zanon, who is a pioneer in developing the new therapy, treats a wide variety of arrhythmias from cardiac devices to ablations of AF/VT. His main investigation fields are CRT, LV lead placement optimisation and multipoint pacing.
�Combining multipoint pacing with optimal positioning of the LV lead on the basis of electrical delay and hemodynamics enhances reverse remodelling. It also improves clinical outcomes beyond the effect due to conventional cardiac resynchronization therapy,� he said.
According to Dr Zanon, lifestyle management is the key to leading a healthy life and avoiding possibility of heart failure.
The technology advocated by Dr Zanon enables a revolutionary approach by providing options that benefit patients suffering from heart failure. This mode of therapy enhances quality of life for people who suffer heart failures and do not respond to expectation levels of other pacing alternatives.
Approximately 23 million people around the world are afflicted with congestive heart failure and two million new cases are diagnosed worldwide every year. Studies have shown that CRT can improve the quality of life for many patients with heart failure.
